Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey.

To assess risk factors for development of candidal blood stream infections (CBSIs), a prospective cohort study was performed at 6 sites that involved all patients admitted to the surgical intensive care unit (SICU) for >48 h over a 2-year period. Among 4276 such patients, 42 CBSIs occurred (9.82 CBSIs per 1000 admissions). The overall incidence was 0.98 CBSIs per 1000 patient days and 1.42 per 1000 SICU days with a central venous catheter in place. In multivariate analysis, factors independently associated with increased risk of CBSI included prior surgery (relative risk [RR], 7.3), acute renal failure (RR, 4.2), receipt of parenteral nutrition (RR, 3.6), and, for patients who had undergone surgery, presence of a triple lumen catheter (RR, 5.4). Receipt of an antifungal agent was associated with decreased risk (RR, 0.3). Prospective clinical studies are needed to identify which antifungal agents are most protective and which high-risk patients will benefit from antifungal prophylaxis.

[1]  L. Saiman,et al.  Elucidating the Origins of Nosocomial Infections with Candida albicans by DNA Fingerprinting with the Complex Probe Ca3 , 1999, Journal of Clinical Microbiology.

[2]  L. Saiman,et al.  National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[3]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  P. Francioli,et al.  Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. , 1999, Critical care medicine.

[5]  M. Pfaller,et al.  Trends in Antifungal Use and Epidemiology of Nosocomial Yeast Infections in a University Hospital , 1999, Journal of Clinical Microbiology.

[6]  E. Bow,et al.  Randomized Placebo-Controlled Trial of Fluconazole Prophylaxis for Neutropenic Cancer Patients: Benefit Based on Purpose and Intensity of Cytotoxic Therapy , 1999 .

[7]  E. Bow,et al.  Randomized placebo-controlled trial of fluconazole prophylaxis for neutropenic cancer patients: benefit based on purpose and intensity of cytotoxic therapy. The Canadian Fluconazole Prophylaxis Study Group. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  M. A. Martin,et al.  National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. , 1998, Diagnostic microbiology and infectious disease.

[9]  D. Dean,et al.  Surgical Perspective on Invasive Candida Infections , 1998, World Journal of Surgery.

[10]  J. Karlowsky,et al.  Candidemia in a Canadian tertiary care hospital from 1976 to 1996. , 1997, Diagnostic microbiology and infectious disease.

[11]  S. Fridkin,et al.  Epidemiology of nosocomial fungal infections , 1996, Clinical microbiology reviews.

[12]  A. Antoniadou,et al.  Epidemiology, diagnosis, and therapy of fungal infections in surgery. , 1996 .

[13]  D. Snydman,et al.  The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. , 1996, The American journal of medicine.

[14]  W. Jarvis.  Epidemiology of nosocomial fungal infections, with emphasis on Candida species. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  B. Doebbeling,et al.  Investigation of Candida albicans transmission in a surgical intensive care unit cluster by using genomic DNA typing methods , 1995, Journal of clinical microbiology.

[16]  R. Auckenthaler,et al.  Candida Colonization and Subsequent Infections in Critically III Surgical Patients , 1994, Annals of surgery.

[17]  J. Savino,et al.  Routine prophylactic antifungal agents (clotrimazole, ketoconazole, and nystatin) in nontransplant/nonburned critically ill surgical and trauma patients. , 1994, The Journal of trauma.

[18]  F. Bongard,et al.  Candida sepsis in surgical patients. , 1993, American journal of surgery.

[19]  J. Sobel,et al.  Nosocomial acquisition of Candida albicans: an epidemiologic study. , 1993, The Journal of infectious diseases.

[20]  C. Beck-Sague,et al.  Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. , 1993, The Journal of infectious diseases.

[21]  H. Horowitz,et al.  Fluconazole Prophylaxis of Fungal Infections in Patients with Acute Leukemia: Results of a Randomized Placebo-Controlled, Double-Blind, Multicenter Trial , 1993, Annals of Internal Medicine.

[22]  V. Fraser,et al.  Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  J. L. Goodman,et al.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.

[24]  W. Martone,et al.  Predominant pathogens in hospital infections. , 1992, The Journal of antimicrobial chemotherapy.

[25]  I. Chopra,et al.  Uptake of minocycline by Escherichia coli. , 1992, The Journal of antimicrobial chemotherapy.

[26]  M G Rinaldi,et al.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. , 1991, The New England journal of medicine.

[27]  J. Edwards.  Invasive candida infections--evolution of a fungal pathogen. , 1991, The New England journal of medicine.

[28]  H. Richet,et al.  Risk factors for candidemia in patients with acute lymphocytic leukemia. , 1991, Reviews of infectious diseases.

[29]  B. Leventhal,et al.  Invasive fungal disease in pediatric acute leukemia patients with fever and neutropenia during induction chemotherapy: a multivariate analysis of risk factors. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[31]  B. Strom,et al.  Risk factors for nosocomial candidemia: a case-control study in adults without leukemia. , 1989, The American journal of medicine.

[32]  R. Woolson,et al.  Risk factors for hospital-acquired candidemia. A matched case-control study. , 1989, Archives of internal medicine.

[33]  J. Sobel,et al.  Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. , 1989, Reviews of infectious diseases.

[34]  David W. Hosmer,et al.  Best subsets logistic regression , 1989 .

[35]  R F Woolson,et al.  Hospital-acquired candidemia. The attributable mortality and excess length of stay. , 1988, Archives of internal medicine.

[36]  C. Hill,et al.  Risk factors for candidemia in cancer patients: a case-control study , 1988, Journal of clinical microbiology.

[37]  G. M. Woerlee.  ASA — Physical Status Classification , 1988 .

[38]  E. Draper,et al.  APACHE II: A severity of disease classification system , 1985, Critical care medicine.

[39]  S. Schrier,et al.  Multivariate analysis of factors associated with invasive fungal disease during remission induction therapy for acute myelogenous leukemia , 1984, Cancer.

[40]  W. R. Mccabe,et al.  Gram-negative bacteremia: IV. Re-evaluation of clinical features and treatment in 612 patients , 1980 .

[41]  E. Spitznagel,et al.  ASA Physical Status Classifications: A Study of Consistency of Ratings , 1978, Anesthesiology.

[42]  O. Miettinen,et al.  Estimability and estimation in case-referent studies. , 1976, American journal of epidemiology.

[43]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .

[44]  J. Lewis,et al.  Gram-negative bacteremia. , 1969, The Johns Hopkins medical journal.

[45]  G. Jackson,et al.  Gram-Negative Bacteremia: I. Etiology and Ecology , 1962 .